Delivery Order SPE2DB20D3103-SPE2DB25FP3T3
Award Date
7/2/25
Potential Completion Date
7/3/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML to the Defense Logistics Agency (DLA), a defense agency. The $9,178.23 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 28, 2025. The contract has a completion date of May 29, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML to the Defense Logistics Agency (DLA). The $9,738.66 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp on December 19, 2024, with a completion date of December 20, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery...
The federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price of $11,362.20 and a completion date of December 5, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $15,486.20 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and is not designated as a set-aside contract. The award has an ultimate completion date of June 13, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $4,966.07. The contract is a firm fixed price delivery order, without a set-aside designation, and has an ultimate completion date of May 23, 2025. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,879.98 delivery order is for the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, with a completion date of July 9, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the delivery of the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML to the Defense Logistics Agency (DLA), a defense agency. The $3,270.42 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 11, 2025, with an ultimate completion date of June 12, 2025. This contract is not a set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award from the Defense Logistics Agency (DLA) is for the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The $62,074.20 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024 with an ultimate completion date of October 29, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a delivery order for OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, awarded to the prime contractor Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price of $1,463.29 and an ultimate completion date of May 16, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The company holds a significant $999,999,999.00...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used to treat diabetes, to the Defense Logistics Agency (DLA). The $4,499.31 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 1, 2025, with a completion date of July 2, 2025. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract...